JACOBUS 25 102
Pill imprint JACOBUS 25 102 has been identified as Dapsone 25 mg.
Dapsone is used in the treatment of toxoplasmosis, prophylaxis; dermatitis herpetiformis; pneumocystis pneumonia prophylaxis; pneumocystis pneumonia; leprosy (and more), and belongs to the drug class leprostatics. Risk cannot be ruled out during pregnancy.
Dapsone 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Dapsone Images
- Imprint:
-
JACOBUS
25 102 - Strength:
- 25 mg
- Color:
- White
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
magnesium stearate
microcrystalline cellulose
corn starch
- Drug Class:
- Leprostatics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Jacobus Pharmaceutical Company
- National Drug Code (NDC):
- 49938-0102
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-2817 | Physicians Total Care Inc (repackager) |
| 55289-0188 | PDRX Pharmaceuticals Inc (repackager) |
| 68258-9091 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Dapsone resources
Search Again
